Eddie Blair

Dr Eddie Blair is currently Chair of Virokine Therapeutics, was CEO at GeneFirst Ltd and Integrated Magnetic Systems Ltd, and has held Executive and Non-Executive Directorships at Public Limited Companies.

He also remains Managing Director of Integrated Medicines Ltd (IML), a company co-founded in 2003 to enable personalised medicine by combining diagnostic-type testing with new and existing medicines, in part using intellectual capital from GSK.

Eddie is a visiting scholar to the Cambridge University Masters in Bioscience Enterprise and Masters in Science & Technology programmes, and is an external assessor for Innovate UK and Asthma UK on various funding programmes.

After a BSc First Class Honours at Glasgow University, he trained in biochemical and molecular virology at the National Institute for Medical Research in Mill Hill, London (PhD awarded December 1984) and at the University of California (Irvine CA). He returned to the UK in 1988 and spent 15 years with Wellcome, GlaxoWellcome and GlaxoSmithKline before forming IML. His with-merit MBA was awarded in July 2006 and included financial strategy, strategy development and creativity & innovation modules.